dx 9065a has been researched along with thiophenes in 5 studies
Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (thiophenes) | Trials (thiophenes) | Recent Studies (post-2010) (thiophenes) |
---|---|---|---|---|---|
92 | 7 | 8 | 17,012 | 1,961 | 8,038 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haas, S; Kubitza, D | 1 |
Doggrell, SA | 1 |
Arora, R; Chandrasekar, S; Loomba, R; Shah, P | 1 |
Burghaus, R; Coboeken, K; Gaub, T; Kuepfer, L; Lippert, J; Mueck, W; Sensse, A; Siegmund, HU; Weiss, W | 1 |
Rauch, BH; Rosenkranz, AC; Schrör, K | 1 |
3 review(s) available for dx 9065a and thiophenes
Article | Year |
---|---|
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Injections, Intravenous; Injections, Subcutaneous; Morpholines; Naphthalenes; Oligosaccharides; Polysaccharides; Propionates; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism | 2006 |
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes | 2011 |
The need for novel anticoagulation therapy in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Cyclic N-Oxides; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Morpholines; Naphthalenes; Polysaccharides; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin | 2013 |
2 other study(ies) available for dx 9065a and thiophenes
Article | Year |
---|---|
Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation.
Topics: Anticoagulants; Azetidines; Benzylamines; Blood Circulation; Blood Coagulation; Computer Simulation; Enoxaparin; Humans; Models, Biological; Morpholines; Naphthalenes; Partial Thromboplastin Time; Propionates; Rivaroxaban; Thiophenes; Translational Research, Biomedical; Treatment Outcome; Warfarin | 2011 |
Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells.
Topics: Anticoagulants; Antithrombins; Aorta; Blood Coagulation; Cells, Cultured; DNA; Factor Xa; Factor Xa Inhibitors; Gene Expression Regulation; Hirudins; Humans; Inflammation Mediators; Morpholines; Myocytes, Smooth Muscle; Naphthalenes; Propionates; Rivaroxaban; Thiophenes; Thrombin | 2011 |